Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
Chapuis, Aude G., Lee, Sylvia M., Thompson, John A., Roberts, Ilana M., Margolin, Kim A., Bhatia, Shailender, Sloan, Heather L., Lai, Ivy, Wagener, Felecia, Shibuya, Kendall, Cao, Jianhong, Wolchok, JLanguage:
english
Journal:
The Journal of Experimental Medicine
DOI:
10.1084/jem.20152021
Date:
May, 2016
File:
PDF, 1.61 MB
english, 2016